The CDC says the number of people affected by an E.coli outbreak linked to Costco chicken salad will likely grow.» Read More
Drugmaker Valeant is in dire need of a total leadership turnover, said former Medtronic CEO Bill George on Thursday.
Internal company records show a key GNC official knew as far back as 2007 the ingredient wasn't natural, the suit alleges. USAT Today reports.
Valeant has fallen 40 percent this week, and some traders appear to be betting on another big tumble in the next few months.
Is Valeant taking legal action against itself? The answer may come down to an odd classification known as the "variable interest entity."
Activist investor Bill Ackman made a huge bet on Valeant Pharmaceuticals Wednesday
The market for influenza vaccines globally is estimated to be about $4 billion, and growing.
The CDC recommends everyone in the U.S. older than six months receive a flu shot. Here's what you need to know.
Shareholders will get their say on two big deals: Aetna's $37B bid for Humana, and Centene's $6.3B bid for Health Net.
For Valeant investors, the bad news is that the bad news seemingly keeps on coming.
Repealing the Affordable Care Act? Unlikely. Reforming it? Possible.
Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.
Ten million people are projected to have coverage from government health exchanges by the end of 2016, a modest increase.
One of the most valuable Silicon Valley startups is under fire, according to the Wall Street Journal.
Voter initiatives in California and Ohio to control prescription med prices have ramifications for the presidential contest.
Turing Pharmaceuticals is not saying if it's actually cutting the exorbitant price of Daraprim as its CEO has promised.
London's Royal Free Hospital says Pauline Cafferkey, who is being treated for complications resulting from Ebola, is now critically ill.
The same drug development news that's hurting Eli Lilly shares might be good for Amgen and Sanofi-Regeneron.
A strong majority say the Affordable Care Act will play an important role in their vote.
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.
Stock markets are fixated on Fed policy, but two experts believe investors should forget the U.S. central bank for now.
Get the best of CNBC in your inbox